You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

CLINICAL TRIALS PROFILE FOR ADVATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for ADVATE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00168051 ↗ Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A Withdrawn Wyeth is now a wholly owned subsidiary of Pfizer Phase 4 2005-04-01 The purpose of the study is to compare the pharmacokinetic parameters of ReFacto and Advate, using the chromogenetic substrate assay to measure plasma Factor VIII activity in plasma.
NCT00189982 ↗ Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101 Completed Baxalta now part of Shire Phase 2/Phase 3 2004-12-17 The purpose of this study is to evaluate whether rAHF-PFM is safe and effective in the treatment of children with hemophilia A. The study is open to pediatric patients in Canada who completed Baxter Study 060101.
NCT00189982 ↗ Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101 Completed Baxalta US Inc. Phase 2/Phase 3 2004-12-17 The purpose of this study is to evaluate whether rAHF-PFM is safe and effective in the treatment of children with hemophilia A. The study is open to pediatric patients in Canada who completed Baxter Study 060101.
NCT00214734 ↗ ADVATE Post Authorization Safety Surveillance Completed Baxter BioScience 2004-10-14 The primary objective of this post-authorization safety surveillance is to measure the incidence of adverse events that are at least possibly related to ADVATE use, in subjects receiving ADVATE in routine clinical practice.
NCT00214734 ↗ ADVATE Post Authorization Safety Surveillance Completed Baxalta now part of Shire 2004-10-14 The primary objective of this post-authorization safety surveillance is to measure the incidence of adverse events that are at least possibly related to ADVATE use, in subjects receiving ADVATE in routine clinical practice.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ADVATE

Condition Name

Condition Name for ADVATE
Intervention Trials
Hemophilia A 14
Severe Hemophilia A 3
Bone Disease 1
Congenital Bleeding Disorder 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for ADVATE
Intervention Trials
Hemophilia A 20
Blood Coagulation Disorders 1
Bone Diseases 1
Von Willebrand Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for ADVATE

Trials by Country

Trials by Country for ADVATE
Location Trials
United States 80
China 10
Italy 9
Germany 7
India 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for ADVATE
Location Trials
California 6
Louisiana 5
Pennsylvania 5
Indiana 5
New York 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for ADVATE

Clinical Trial Phase

Clinical Trial Phase for ADVATE
Clinical Trial Phase Trials
Phase 4 6
Phase 3 3
Phase 2/Phase 3 1
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for ADVATE
Clinical Trial Phase Trials
Completed 12
Unknown status 3
Active, not recruiting 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ADVATE

Sponsor Name

Sponsor Name for ADVATE
Sponsor Trials
Baxalta now part of Shire 5
Baxalta US Inc. 5
Baxter Healthcare Corporation 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for ADVATE
Sponsor Trials
Industry 30
Other 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.